K Zhang, J Chen, H Zhou, Y Chen, Y Zhi,
B Zhang… - Cell Death & …, 2018 - nature.com
Sorafenib is currently the only systemic agent approved for treatment of advanced
hepatocellular carcinoma (HCC). However, intrinsic and acquired resistance to sorafenib …